EA200501529A1 - Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат - Google Patents
Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержатInfo
- Publication number
- EA200501529A1 EA200501529A1 EA200501529A EA200501529A EA200501529A1 EA 200501529 A1 EA200501529 A1 EA 200501529A1 EA 200501529 A EA200501529 A EA 200501529A EA 200501529 A EA200501529 A EA 200501529A EA 200501529 A1 EA200501529 A1 EA 200501529A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- benzothiadiazine
- contain
- production
- pharmaceutical compositions
- new compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Соединения формулы (I)в которой Х представляет собой атом кислорода или серы,Rпредставляет собой алкил, замещенный одним или несколькими атомами галогена,Rпредставляет собой водород, галоген или ОН,Rпредставляет собой Rили Y-R, где R, Y и Rимеют значения, указанные в описании. Лекарственные средства.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0411691A FR2877342B1 (fr) | 2004-11-03 | 2004-11-03 | Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200501529A1 true EA200501529A1 (ru) | 2006-06-30 |
Family
ID=34950936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501529A EA200501529A1 (ru) | 2004-11-03 | 2005-10-28 | Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат |
Country Status (18)
Country | Link |
---|---|
US (1) | US7262191B2 (ru) |
EP (1) | EP1655299A1 (ru) |
JP (1) | JP2006131634A (ru) |
KR (1) | KR20060052411A (ru) |
CN (1) | CN1769276A (ru) |
AR (1) | AR051414A1 (ru) |
AU (1) | AU2005229699A1 (ru) |
BR (1) | BRPI0505262A (ru) |
CA (1) | CA2524869A1 (ru) |
EA (1) | EA200501529A1 (ru) |
FR (1) | FR2877342B1 (ru) |
GE (1) | GEP20074217B (ru) |
MA (1) | MA27918A1 (ru) |
MX (1) | MXPA05011819A (ru) |
NO (1) | NO20055124L (ru) |
NZ (1) | NZ543359A (ru) |
SG (1) | SG122000A1 (ru) |
ZA (1) | ZA200508928B (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105294599B (zh) * | 2015-09-17 | 2017-09-22 | 三峡大学 | 一种噻二嗪类化合物及其不对称的合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2722502B1 (fr) | 1994-07-12 | 1996-08-23 | Adir | Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent |
WO1998012185A1 (en) * | 1996-09-17 | 1998-03-26 | The Regents Of The University Of California | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
HUP0101280A3 (en) * | 1998-02-18 | 2003-02-28 | Neurosearch As | Positive ampa receptor modulator compounds and their use |
FR2801587B1 (fr) * | 1999-11-30 | 2002-01-11 | Adir | Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2833955B1 (fr) * | 2001-12-21 | 2004-01-30 | Servier Lab | Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2833950B1 (fr) * | 2001-12-21 | 2005-12-16 | Servier Lab | Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2833956B1 (fr) * | 2001-12-21 | 2004-01-30 | Servier Lab | Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2004
- 2004-11-03 FR FR0411691A patent/FR2877342B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-17 SG SG200506774A patent/SG122000A1/en unknown
- 2005-10-17 MA MA28555A patent/MA27918A1/fr unknown
- 2005-10-28 EA EA200501529A patent/EA200501529A1/ru unknown
- 2005-10-31 CA CA002524869A patent/CA2524869A1/fr not_active Abandoned
- 2005-11-02 NO NO20055124A patent/NO20055124L/no not_active Application Discontinuation
- 2005-11-02 KR KR1020050104303A patent/KR20060052411A/ko not_active Application Discontinuation
- 2005-11-02 NZ NZ543359A patent/NZ543359A/en unknown
- 2005-11-02 GE GEAP20059037A patent/GEP20074217B/en unknown
- 2005-11-02 EP EP05292309A patent/EP1655299A1/fr not_active Withdrawn
- 2005-11-02 AR ARP050104583A patent/AR051414A1/es unknown
- 2005-11-03 US US11/266,072 patent/US7262191B2/en not_active Expired - Fee Related
- 2005-11-03 CN CNA2005101249239A patent/CN1769276A/zh active Pending
- 2005-11-03 AU AU2005229699A patent/AU2005229699A1/en not_active Abandoned
- 2005-11-03 MX MXPA05011819A patent/MXPA05011819A/es unknown
- 2005-11-03 ZA ZA200508928A patent/ZA200508928B/en unknown
- 2005-11-03 BR BRPI0505262-9A patent/BRPI0505262A/pt not_active Application Discontinuation
- 2005-11-04 JP JP2005320479A patent/JP2006131634A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SG122000A1 (en) | 2006-05-26 |
CN1769276A (zh) | 2006-05-10 |
GEP20074217B (en) | 2007-10-10 |
BRPI0505262A (pt) | 2006-07-11 |
MXPA05011819A (es) | 2006-05-08 |
EP1655299A1 (fr) | 2006-05-10 |
JP2006131634A (ja) | 2006-05-25 |
KR20060052411A (ko) | 2006-05-19 |
ZA200508928B (en) | 2006-07-26 |
US7262191B2 (en) | 2007-08-28 |
NO20055124D0 (no) | 2005-11-02 |
CA2524869A1 (fr) | 2006-05-03 |
AU2005229699A1 (en) | 2006-05-18 |
FR2877342B1 (fr) | 2007-01-26 |
NO20055124L (no) | 2006-05-04 |
US20060094713A1 (en) | 2006-05-04 |
MA27918A1 (fr) | 2006-06-01 |
FR2877342A1 (fr) | 2006-05-05 |
AR051414A1 (es) | 2007-01-10 |
NZ543359A (en) | 2007-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE433447T1 (de) | Pyrimiidinverbindungen | |
TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
DK1853602T3 (da) | Kemiske forbindelser | |
DK1853588T3 (da) | Kemiske forbindelser | |
CY1109568T1 (el) | Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων | |
PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
MX2007003108A (es) | Compuestos imidazo-3-il-amina sustituidos y biciclicos. | |
EA201000886A1 (ru) | Органические соединения | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
CY1111269T1 (el) | Ρυθμιστες βενζιμιδαζολης του vr1 | |
DK1751093T3 (da) | Substituerede cyklohexyleddikesyre-derivater | |
EA200800374A1 (ru) | 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции | |
TW200616977A (en) | Enantiomers of selected fused heterocyclics and uses thereof | |
MA32505B1 (fr) | 5-alcynyl-pyrimidines | |
EA200800393A1 (ru) | Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат | |
CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
EA200501530A1 (ru) | Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
ES2333026T3 (es) | Derivados de ciclohexil-1,4-diamina sustituidos. | |
IL176915A0 (en) | Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
ATE478858T1 (de) | Cyclische sulfone, die zur verwendung als bace- inhibitoren geeignet sind | |
TW200621260A (en) | Selected fused heterocyclics and uses thereof | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |